High blood pressure is one of the most common health issues many face in the world today. But with a few lifestyle changes, the risks of suffering from serious conditions as a result of this issue can be lowered, like a few teas.
Express reports that three kinds of herbal teas are known for having properties that can help lower a high blood pressure reading. Herbal teas, or teas in general, are already known for being a healthy option for those who want to lower their risks of developing serious illnesses or those who simply want to stay healthy. Some of the teas that can help lower high blood pressure readings are hibiscus tea, black tea, and oolong tea.
Hibiscus tea has been shown to lower blood pressure in many studies. One study in particular was done over a six-week period, and 65 participants with high blood pressure were given placebo or hibiscus tea. After the study, the researchers found that the participants that drank hibiscus tea had lowered systolic blood pressure - the pressure in the blood vessels when the heart beats - compared to those who only took placebo.
Black tea has also been proven to have properties that can lower blood pressure. This type of tea can improve endothelial cell function or the lining inside the blood vessels. Oolong tea’s blood pressure lowering properties also lower bad cholesterol levels and a lower risk of heart disease.
Tea is not the only drink that has been shown to lower blood pressure readings. Another report reveals that drinks like tomato juice and beetroot juice are shown to lower blood pressure readings. Unsalted tomato juice in particular has been shown to be attributed to lowered blood pressure readings as well as lower levels of bad cholesterol according to a study in Japan.
As for beetroot juice, a study showed that consuming a glass or eight ounces of beetroot juice everyday had lowered blood pressure readings. This is because beetroot also contains nitrate, a compound in the juice that can turn into nitric acid in the blood, relaxing and softening the blood vessels.


Intermittent fasting doesn’t have an edge for weight loss, but might still work for some
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide
FDA Warns Novo Nordisk Over Misleading Ozempic Ad Claims
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
U.S. Officials Express Optimism Over New CDC Director Selection Amid Vaccine Policy Turmoil
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
CDC Acting Director Urges Measles Vaccination as U.S. Cases Surge in 2026
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval 



